high frequency hypermutable pseudomonas aeruginosa cystic fibrosis lung infection 
lungs cystic fibrosis cf patients chronically infected years one lineages pseudomonas aeruginosa bacterial populations adapt highly compartmentalized anatomically deteriorating lung environment cf patients well challenges immune defenses antibiotic therapy selective conditions precisely recent theoretical studies predict evolution mechanisms augment rate variation determination spontaneous mutation rates p aeruginosa isolates cf patients revealed % patients colonized hypermutable mutator strain persisted years patients mutator strains found non-cf patients acutely infected p aeruginosa investigation also reveals link high mutation rates vivo evolution antibiotic resistance 
